AQNEURSA (LEVACETYLLEUCINE)
AQNEURSA (LEVACETYLLEUCINE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: AQNEURSA; Generic name: LEVACETYLLEUCINE; Manufacturer: IntraBio Inc.
| Brand name | AQNEURSA |
|---|---|
| Generic name | LEVACETYLLEUCINE |
| Manufacturer | IntraBio Inc |
| Used for | 1 INDICATIONS AND USAGE AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg. AQNEURSA is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • For females of reproductive potential, verify that the patient is not pregnant prior to initiating treatment. ( 2.1 ) • Recommended dosage ( 2.2 ) Patient Body Weight Morning Dose Afternoon Dose Evening Dose 15 to <25 kg 1 g No Dose 1 g 25 to <35 kg 1 g 1 g 1 g 35 kg or more 2 g 1 g 1 g • See the full prescribing information for administration instructions. ( 2.3 ) 2.1 Important Recommendation Prior to AQNEURSA Treatment Initiation For females of reproductive potent |
| Active ingredient(s) | LEVACETYLLEUCINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f248e55-d1bb-13f9-e063-6294a90a05ce |